FilingReader Intelligence
Sun Pharma appoints Ganorkar as CEO, Shanghvi executive chairman
June 27, 2025 at 09:01 AM UTC•By FilingReader AI
Sun Pharmaceutical Industries (BSE:SUNPHARMA) announced Kirti Ganorkar's appointment as Managing Director, effective September 1, 2025, succeeding Dilip Shanghvi, who will transition to the role of Executive Chairman. Ganorkar, who currently heads Sun Pharma's India Business, has held various leadership positions within the company. Shanghvi will focus on strengthening the company's specialty portfolio and long-term strategy.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
Supplementary Source Documents
BSE:SUNPHARMA•Bombay Stock Exchange
News Alerts
Get instant email alerts when Sun Pharmaceutical Industries publishes news
Free account required • Unsubscribe anytime